Showing results (2281-2290 of 2,860) with videos related to
Sort By:
Pageof 286
Neuropsychobiology|January 1, 1996
Mood effects of zolpidem versus phenobarbital combined with promethazine in an anesthesiological settingT Uhlig, M Hüppe, B Nidermaier, et al.Neuropsychobiology|January 1, 1996
Addition of lithium to chronic antidepressant treatment potentiates presynaptic serotonergic function without changes in serotonergic receptors in the rat cerebral cortexY Okamoto, N Motohasi, H Hayakawa, et al.Neuropsychobiology|January 1, 1996
Influence of moclobemide on cognitive functions of nine depressed patients: pilot trial with neurophysiological and neuropsychological indicesS Galderisi, A Mucci, P Bucci, et al.Neuropsychobiology|April 22, 2008
Association of the homeobox transcription factor gene ENGRAILED 2 with autistic disorder in Chinese childrenPinchen Yang, For-Wey Lung, Yuh-Jyh Jong, et al.Neuropsychobiology|January 26, 2026
Participant experience in a study of dietary counselling plus omega-3 supplementation for the treatment of generalized anxiety disorder among women: A focus group studyMonique Aucoin, Domenique Barbaro, Laura LaChance, et al.Neuropsychobiology|January 11, 1976
Susceptibility to motion sickness and field dependence-independence as measured with the rod and frame testC S Mirabile, B C Glueck, C F StroebelNeuropsychobiology|March 11, 1999
Effect of two antidepressant drugs on REM sleep and EMG activity during sleepM Jobert, P Jähnig, H SchulzNeuropsychobiology|June 27, 2000
(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studiesU D McCann, V Eligulashvili, G A RicaurteNeuropsychobiology|June 27, 2000
Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of changeA C ParrottNeuropsychobiology|June 27, 2000
Potential human neurotoxicity of MDMA ('Ecstasy'): subjective self-reports, evidence from an Italian drug addiction centre and clinical case studiesF SchifanoPageof 286